Brief: Jaguar Health Inc Napo Pharmaceuticals Submits Funding Application To Barda For Development Of NP-300 Drug Candidate For Cholera-Related Diarrhea
09/08/2023 14:59
Aug 9 (Reuters) - Jaguar Health Inc JAGX.O :
* JAGUAR HEALTH INC: NAPO PHARMACEUTICALS SUBMITS FUNDING
APPLICATION TO BARDA FOR DEVELOPMENT OF NP-300 DRUG CANDIDATE
FOR CHOLERA-RELATED DIARRHEA
Source text for Eikon: ID:
Further company coverage: JAGX.O